OTC derivatives challenge

OPEN PLATFORM : LATENTZERO

The growth in the use of over-the-counter (OTC) derivatives on the buy side has thrown up a number of challenges to those firms using such instruments, not least of which involve accurate valuations and efficient processing. Alex Loucaides argues that it's high time that technologists start addressing these challenges by providing users with integrated, buy-side oriented platforms and not re-packaged sell-side technology.

The last year has seen significant growth in trading OTC derivatives

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: